Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Aquabounty Technologies (AQB) Asset Writedowns and Impairment (2024 - 2025)

Aquabounty Technologies' Asset Writedowns and Impairment history spans 2 years, with the latest figure at $13.2 million for Q4 2025.

For Q4 2025, Asset Writedowns and Impairment fell 83.78% year-over-year to $13.2 million; the TTM value through Dec 2025 reached $95.5 million, down 26.41%, while the annual FY2025 figure was $14.4 million, 88.88% down from the prior year.
Asset Writedowns and Impairment reached $13.2 million in Q4 2025 per AQB's latest filing, up from $69000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $81.1 million in Q4 2024 to a low of $69000.0 in Q3 2025.